None
Quote | Seelos Therapeutics Inc. (NYSE:SEEL)
Last: | $ |
---|---|
Change Percent: | 2.60% |
Open: | $0.79 |
Close: | $0.79 |
High: | $0.8382 |
Low: | $0.78 |
Volume: | 966,621 |
Last Trade Date Time: | 02/12/2020 04:39:52 pm |
News | Seelos Therapeutics Inc. (NYSE:SEEL)
A recently published review has determined that using psilocybin to manage mental-health conditions doesn’t heighten the risk of paranoia. This discovery comes at a time when public interest in the therapeutic potential of psychedelics is increasing. The review was carried out by resea...
Recent research assessed how patient expectations influenced the outcomes of psychedelic treatments in comparison to conventional treatments. This comes as the global impact of depression is being felt in different parts of the world and the need for alternative treatments increases. For a lo...
Message Board Posts | Seelos Therapeutics Inc. (NYSE:SEEL)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SEEL News Article - Review Examines Trials on Use of Psychedelics by Older Adults | whytestocks | investorshangout | 04/24/2023 6:55:46 PM |
whytestocks: $SEEL News Article - Seelos Therapeutics Doses the First Amyotrophic Lateral Sclerosis | whytestocks | investorshangout | 04/04/2023 4:20:47 PM |
whytestocks: $SEEL News Article - Is Now the Time for Insurers, Employers to Cover Psychedelic Treat | whytestocks | investorshangout | 03/10/2023 5:30:47 PM |
whytestocks: $SEEL News Article - Seelos Therapeutics to Participate in 43rd Annual Cowen Health Car | whytestocks | investorshangout | 02/15/2023 4:25:47 PM |
whytestocks: $SEEL News Article - Seelos Therapeutics Doses First Patients in an Ethnobridging Study | whytestocks | investorshangout | 02/06/2023 1:11:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Seelos Therapeutics Inc. Company Name:
SEEL Stock Symbol:
NYSE Market:
Seelos Therapeutics Inc. Website:
A recently published review has determined that using psilocybin to manage mental-health conditions doesn’t heighten the risk of paranoia. This discovery comes at a time when public interest in the therapeutic potential of psychedelics is increasing. The review was carried out by resea...
Recent research assessed how patient expectations influenced the outcomes of psychedelic treatments in comparison to conventional treatments. This comes as the global impact of depression is being felt in different parts of the world and the need for alternative treatments increases. For a lo...